Winni Maharani

Winni Maharani

Auto-generated profile, based on publicly available information

Winni Maharani

Department of Microbiology, Faculty of Medicine, Universitas Islam Bandung, Bandung, Indonesia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2012 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MRMerrin E Rutherford
Merrin E Rutherford
RRRovina Ruslami
Rovina Ruslami
WMWinni Maharani
Winni Maharani
IYIndria Yulita
Indria Yulita
SLSarah Lovell
Sarah Lovell
Philip HillPhilip Hill
Philip Hill
It is recommended that young child contacts of sputum smear positive tuberculosis cases receive isoniazid preventive therapy (IPT) but reported adherence is low and risk factors for poor adherence in children are largely unknown.

1 December 2012 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
MRM. E. Rutherford
M. E. Rutherford
PHP. C. Hill
P. C. Hill
WMW. Maharani
W. Maharani
LALika Apriani
Lika Apriani
HSH. Sampurno
H. Sampurno
RRR. Ruslami
R. Ruslami
SETTING AND OBJECTIVES: Young children living with infectious tuberculosis (TB) cases are at high risk of infection and disease, and screening is recommended. This is rarely conducted in resource-limited settings. Identifying children most at risk of infection may be useful for setting practical screening policies. DESIGN: Child contacts of smear-positive adult TB patients were invited for Mycobacterium tuberculosis infection and disease screening by symptoms, tuberculin skin test (TST), QuantiFERON®-TB Gold In-Tube assay (QFT-GIT) and chest X-ray. Risk factors for infection were collected using a questionnaire and were calculated separately for TST, for QFT-GIT and for both tests combined. RESULTS: Of 304 screened children 145/302 (48%) were positive using TST, 152/299 (51%) by QFT-GIT and 180/304 (59%) were positive using either or both tests. Positivity for both tests was associated with index case infectivity (acid-fast bacilli [AFB] 3+ vs. AFB 1+: TST OR 2.93, 95%CI 1.59–5.39; QFT-GIT OR 2.28, 95%CI 1.06–4.90) and exposure (child contact's parent is the index case: TST OR 7.04, 95%CI 2.23–22.28; QFT-GIT OR 4.30, 95%CI 1.48–12.45). CONCLUSION: M. tuberculosis infection according to either test was high, supporting screening and preventive treatment. Children of smear-positive TB cases who accompany their parents to the clinic should be prioritised for immediate screening.

1 October 2013 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
MRM. E. Rutherford
M. E. Rutherford
PHP. C. Hill
P. C. Hill
WMW. Maharani
W. Maharani
HSH. Sampurno
H. Sampurno
RRR. Ruslami
R. Ruslami
SETTING: Defaulting from anti-tuberculosis treatment hinders tuberculosis (TB) control. OBJECTIVE: To identify potential defaulters. DESIGN: We conducted a cohort study in newly diagnosed Indonesian TB patients. We administered a questionnaire, prospectively identified defaulters (discontinued treatment ≥2 weeks) and assessed risk factors using Cox's regression. RESULTS: Of 249 patients, 39 (16%) defaulted, 61% in the first 2 months. Default was associated with liver disease (HR 3.40, 95%CI 1.02–11.78), chest pain (HR 2.25, 95%CI 1.06–4.77), night sweats (HR 1.98, 95%CI 1.03–3.79), characteristics of the head of the household (self-employed, HR 2.47, 95%CI 1.15–5.34; patient's mother, HR 7.72, 95%CI 1.66–35.88), household wealth (HR 4.24, 95%CI 1.12–16.09), walking to clinic (HR 4.53, 95%CI 1.39–14.71), being unaccompanied at diagnosis (HR 30.49, 95%CI 7.55–123.07) or when collecting medication (HR 3.34, 95%CI 1.24–8.98) and low level of satisfaction with the clinic (HR 3.85, 95%CI 1.17–12.62) or doctors (HR 2.45, 95%CI 1.18–5.10). Health insurance (HR 0.24, 95%CI 0.07–0.74) and paying for diagnosis (HR 0.14, 95%CI 0.04–0.48) were protective. CONCLUSION: Defaulting is common and occurs early. Interventions that improve clinic services, strengthen patient support and increase insurance coverage may reduce default in Indonesia.

1 April 2012 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
MRM. E. Rutherford
M. E. Rutherford
MNM. Nataprawira
M. Nataprawira
IYI. Yulita
I. Yulita
LALika Apriani
Lika Apriani
WMW. Maharani
W. Maharani
BAB. Alisjahbana
B. Alisjahbana
SETTING AND OBJECTIVES: The tuberculin skin test (TST) has limitations in diagnosing latent tuberculosis (TB) infection (LTBI). Interferon-gamma release assays may improve diagnostic accuracy. We compared QuantiFERON®-TB Gold In-Tube (QFT-GIT) and TST in Indonesian children. DESIGN: Children aged from 6 months to 9 years exposed to a TB case at household and neighbourhood levels were recruited. The children underwent QFT-GIT and TST. Test responsiveness was assessed according to an exposure gradient. RESULTS: A total of 299 household-exposed and 72 neighbourhood-exposed children were analysed. Overall, respectively 46% and 41% were positive using QFT-GIT and the TST. Test positivity increased with exposure (QFT-GIT P value for trend P P = 0.05). BCG-vaccinated children were less likely to be QFT-GIT-positive, while older children were more likely to be QFT-GIT-positive. Both tests had increasing positivity with increasing smear grade. CONCLUSION: QFT-GIT performed similarly to the TST in Indonesian children living with an infectious TB case. Test accuracy was not compromised by young age or BCG vaccination. Our findings suggest that QFT-GIT offers little advantage over the TST in this population. High rates of LTBI diagnosed in household-exposed children by both tests support preventive therapy.

1 August 2020 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
WMWinni Maharani
Winni Maharani
DRDwi Febni Ratnaningsih
Dwi Febni Ratnaningsih
FUFitria Utami
Fitria Utami
FYFajar Awalia Yulianto
Fajar Awalia Yulianto
ADAnneke Dewina
Anneke Dewina
UPUniversitas Padjadjaran
Universitas Padjadjaran
Purpose: Highly active systemic lupus erythematosus (SLE) causes a high risk of tuberculosis (TB) infection in SLE patients in Indonesia, a country in which the disease, especially extrapulmonary TB, is endemic. Interferon (IFN)-γ releasing assay (IGRA) can detect latent or previous TB infection. This study sought to determine latent TB infection and levels of IFN-γ, a key player in various inflammation and autoimmune disease, in patients with SLE and relate findings to disease activity. Patients and Methods: This experimental study included 79 female subjects distributed into three groups of active SLE, quiescent SLE and healthy controls. We used SLE Disease Activity Index– 2000 (SLEDAI-2K) scores to stratify the subjects. Each group underwent IGRA testing using the QuantiFERON-TB Gold Plus kit. Results: We recruited 59 female patients with SLE. The patients had a median age and disease duration 30 and 5 years, respectively. Statistical analysis using the Kruskal–Wallis test showed that active condition, high SLEDAI-2K score and immunosuppressive therapies affect IGRA results. Specifically, healthy controls (n=20) were most likely to have negative IGRA results (67.09%), whilst 27.27% of active cases (n=33) and 3.85% of quiescent cases (n=26) had indeterminate results (p=0.02). The number of immunosuppressant therapies was significantly negatively correlated with IFN-γ (p=0.004). No difference in IFN-γ concentration was detected amongst the active and other groups (p> 0.05). Conclusion: High-activity SLE and immunosuppressive therapies cause dysregulation of the immune response, which, in turn, influences IGRA results. Thus, additional testing is necessary to detect TB infection in patients with SLE.

9 August 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MRMerrin Rutherford
Merrin Rutherford
BABachti Alisjahbana
Bachti Alisjahbana
WMWinni Maharani
Winni Maharani
HSHedy Sampurno
Hedy Sampurno
RCReinout van Crevel
Reinout van Crevel
PHPhilip C. Hill
Philip C. Hill
As part of a formal evaluation of the Quantiferon-Gold in-tube assay (QFT-IT) for latent TB infection we compared its sensitivity to the tuberculin skin test (TST) in confirmed adult TB cases in Indonesia. Smear-positive TB disease was used as a proxy gold standard for latent TB infection. We compared the sensitivity of QFT-IT and TST in 98 sputum smear and chest x-ray positive TB cases and investigated risk factors for negative and discordant results in both tests. Both tests showed high sensitivity; (QFT-IT; 88.7%: TST; 94.9%), not significantly different from each other (p value 0.11). Very high sensitivity was seen when tests were combined (98.9%). There were no variables significantly associated with discordant results or with a negative TST. For QFT-IT which particular staff member collected blood was significantly associated with test positivity (p value 0.01). Study limitations include small sample size and lack of culture confirmation or HIV test results. The QFT-IT has similar sensitivity in Indonesian TB cases as in other locations. However, QFT-IT, like the TST cannot distinguish active TB disease from LTBI. In countries such as Indonesia, with high background rates of LTBI, test specificity for TB disease will likely be low. While our study was not designed to evaluate the QFT-IT in the diagnosis of active TB disease in TB suspects, the data suggest that a combination of TST and QFT-IT may prove useful for ruling out TB disease. Further research is required to explore the clinical role of QFT-IT in combination with other TB diagnostic tests.